Gilead Sciences Inc - Company & Market Research Reports

Home /
Companies /
Gilead Sciences Inc

Founded in 1987 Gilead Sciences is a biopharmaceutical company focused on developing innovative treatments for life threatening illnesses. Their areas of research include HIV/AIDs, Liver Diseases, Hematology, Oncology, Cardiovascular and Respiratory disease. Gilead Sciences is based in California, USA and their product portfolio consists of well-known treatments like Atripla, Sovaldi, Zydelig, Viread and many more.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 166
Infectious Diseases Drugs 125
Genomics 102
Liver and Kidney Disorders Drugs 69
Immune Disorders Drugs 60
Drug Discovery 55
Pharmaceuticals 53
Cardiovascular Drugs 47
Biopharmaceuticals 44
Biotechnology 41
Leukemia Drugs 37
HIV/AIDS Drugs 36
Clinical Trials 31
Lymphoma Drugs 30
Respiratory Drugs 29
Allergy and Immunology 28
Musculoskeletal Disorders Drugs 27
Enzymes 26
Pulmonary Medicine 23
Oncology 21
Central Nervous System Drugs 20
Infusions and Injectables 19
Drug Delivery 19
Pharmaceutical Manufacturing 19
Gastrointestinal Drugs 13
Infectious Disease Testing 12
Vaccines 12
Endocrine and Metabolic Disorders Drugs 11
Healthcare Services 10
Diagnostics 10
Hematology 10
Hematological Drugs 10
Sexual and Reproductive Health Drugs 10
Antibiotics 9
Pharmaceutical Intermediates 8
Therapeutic Area 8
Optical Disorders Drugs 8
Breast Cancer Drugs 8
Stem Cells 8
Women's Health 7
Drugs by Therapeutic Area 6
Company Reports 5
Hepatology 5
Lung Cancer Drugs 5
Colon Cancer Drugs 5
Analgesics 5
Needles and Syringes 5
Nanomedicine 5
Liver Cancer Drugs 4
Cervical Cancer Drugs 4
Bladder Cancer Drugs 4
Anesthetic Drugs 4
Biomarkers 4
Dermatology 4
Skin Cancer Drugs 4
Dermatological Drugs 4
Immunosuppressive Drugs 4
Addiction Disorders Drugs 3
Generic Drugs 3
Prostate Cancer Drugs 3
Dental 3
Optical 3
Medical Devices 3
Over the Counter (OTC) Drugs 3
Mental Disorders Drugs 3
Biosimilars and Biosuperiors 3
Pediatrics 3
E-Healthcare 2
Pharmacoeconomics 2
Ovarian Cancer Drugs 2
Brain Cancer Drugs 2
In Vitro Diagnostics 2
Cancer Vaccines 2
Kidney Cancer Drugs 2
Vitamins and Dietary Supplements 2
Laboratory Equipment 2
Gastroenterology 2
Cardiology 2
Urological Disorders Drugs 2
Animal Pharmaceuticals 1
Neurology 1
Urology and Nephrology 1
Fertility Services 1
Proteomics 1
Cardiovascular Devices 1
Home Testing and Home Healthcare 1
Healthcare 1
Managed Care 1
Transdermal and Transmucosal Drug Delivery 1
Inhalers and Nebulisers 1
Blood Banking 1
Hospital Management 1
Surgical Procedures 1
Pancreatic Cancer Drugs 1
Thyroid Cancer Drugs 1
Uterine Cancer Drugs 1
Anatomy 1
Endocrinology 1
Alzheimer's Disease Drugs 1
Asthma Drugs 1
Bronchitis Drugs 1
Schizophrenia Drugs 1
Psoriasis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



281 reviews

1,042 Results (Page 30 of 53)
- Relevance
  Sort by

Non-alcoholic Steatohepatitis Clinical Trials - Global Strategic Business Report

 Report
November 2025
144 Pages
Global

From

€5224EUR$5,850USD£4,573GBP

Pulmonary Embolism Market Report 2025

 Report
March 2025
200 Pages
Global

From

€4010EUR$4,490USD£3,510GBP

Hepatitis B Virus (HBV) Market Report 2025

 Report
September 2025
250 Pages
Global

From

€4010EUR$4,490USD£3,510GBP

Nanomedicine Market - Forecasts from 2023 to 2028

 Report
September 2023
146 Pages
Global

From

€3974EUR$4,450USD£3,478GBP

Condyloma - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1429EUR$1,600USD£1,251GBP

€1786EUR$2,000USD£1,563GBP

NEED HELP FINDING THE RIGHT PRODUCT? Olha will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Liposome Drug Delivery Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2023 to 2031

 Report
November 2023
115 Pages
Global

From

€4019EUR$4,500USD£3,517GBP

Multiple Myeloma Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033

 Report
May 2025
200 Pages
Global

From

€2224EUR$2,490USD£1,946GBP

Cystitis- Pipeline Insight, 2025

 Clinical Trials
April 2025
80 Pages
Global

From

€1072EUR$1,200USD£938GBP

€1340EUR$1,500USD£1,172GBP

Viral Hepatitis Market Report 2025

 Report
March 2025
200 Pages
Global

From

€4010EUR$4,490USD£3,510GBP

Congestive Heart Failure Market - Global Forecast 2025-2032

 Report
November 2025
186 Pages
Global

From

€3166EUR$3,545USD£2,771GBP

€3518EUR$3,939USD£3,079GBP

West Nile Virus - Global Strategic Business Report

 Report
November 2025
169 Pages
Global

From

€5224EUR$5,850USD£4,573GBP

Antifungal Drugs - Global Strategic Business Report

 Report
November 2025
179 Pages
Global

From

€5224EUR$5,850USD£4,573GBP

Cytomegalovirus (CMV) Treatment - Global Strategic Business Report

 Report
November 2025
384 Pages
Global

From

€5224EUR$5,850USD£4,573GBP

Anti-Infectives - Global Strategic Business Report

 Report
November 2025
158 Pages
Global

From

€5224EUR$5,850USD£4,573GBP

Bird Flu Treatment Market - Global Strategic Business Report

 Report
November 2025
285 Pages
Global

From

€5224EUR$5,850USD£4,573GBP

Cutaneous and Systemic Leishmaniasis Market - Global Strategic Business Report

 Report
November 2025
473 Pages
Global

From

€5224EUR$5,850USD£4,573GBP

Candidiasis Therapeutics Market - Global Strategic Business Report

 Report
November 2025
474 Pages
Global

From

€5224EUR$5,850USD£4,573GBP

Oral Antivirals Market - Global Strategic Business Report

 Report
November 2025
380 Pages
Global

From

€5224EUR$5,850USD£4,573GBP

Pseudomonas Aeruginosa Infection Treatment Market - Global Strategic Business Report

 Report
November 2025
273 Pages
Global

From

€5224EUR$5,850USD£4,573GBP

Neglected Tropical Disease Treatment - Global Strategic Business Report

 Report
November 2025
294 Pages
Global

From

€5224EUR$5,850USD£4,573GBP

1,042 Results (Page 30 of 53)
- 1
- 28
- 29
- 30
- 31
- 32

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.